Hsu-Min Sung

Prof. Hsu-Min Sung

Universitätsmedizin Göttingen (UMG)
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2023 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
HSHsu-Min Sung
Hsu-Min Sung
JSJohanna Schott
Johanna Schott
PBPhilipp Boss
Philipp Boss
JLJanina A. Lehmann
Janina A. Lehmann
MHMarius Roland Hardt
Marius Roland Hardt
GSGeorg Stoecklin
Georg Stoecklin
Current models posit that nuclear speckles (NSs) serve as reservoirs of splicing factors and facilitate posttranscriptional mRNA processing. Here, we discovered that ribotoxic stress induces a profound reorganization of NSs with enhanced recruitment of factors required for splice-site recognition, including the RNA-binding protein TIAR, U1 snRNP proteins and U2-associated factor 65, as well as serine 2 phosphorylated RNA polymerase II. NS reorganization relies on the stress-activated p38 mitogen-activated protein kinase (MAPK) pathway and coincides with splicing activation of both pre-existing and newly synthesized pre-mRNAs. In particular, ribotoxic stress causes targeted excision of retained introns from pre-mRNAs of immediate early genes (IEGs), whose transcription is induced during the stress response. Importantly, enhanced splicing of the IEGs ZFP36 and FOS is accompanied by relocalization of the corresponding nuclear mRNA foci to NSs. Our study reveals NSs as a dynamic compartment that is remodeled under stress conditions, whereby NSs appear to become sites of IEG transcription and efficient cotranscriptional splicing.

14 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
YCYing chen cheng
Ying chen cheng
YCYu-An Chang
Yu-An Chang
YCYi-Jen Chen
Yi-Jen Chen
HSHsu-Min Sung
Hsu-Min Sung
IBIvan Bogeski
Ivan Bogeski
Hui-Min David WangHui-Min David Wang
Hui-Min David Wang
Different types of cells, such as endothelial cells, tumor-associated fibroblasts, pericytes, and immune cells, release extracellular vesicles (EVs) in the tumor microenvironment. The components of EVs include proteins, DNA, RNA, and microRNA. One of the most important functions of EVs is the transfer of aforementioned bioactive molecules, which in cancer cells may affect tumor growth, progression, angiogenesis, and metastatic spread. Furthermore, EVs affect the presentation of antigens to immune cells via the transfer of nucleic acids, peptides, and proteins to recipient cells. Recent studies have also explored the potential application of EVs in cancer treatment. This review summarizes the mechanisms by which EVs regulate melanoma development, progression, and their potentials to be applied in therapy. We initially describe vesicle components; discuss their effects on proliferation, anti-melanoma immunity, and drug resistance; and finally focus on the effects of EV-derived microRNAs on melanoma pathobiology. This work aims to facilitate our understanding of the influence of EVs on melanoma biology and initiate ideas for the development of novel therapeutic strategies.

11 December 2018 in EMBO Reports
Verified
Journal Article
Open access
PDF file
VLvanesa Lafarga
vanesa Lafarga
HSHsu-Min Sung
Hsu-Min Sung
KHKatharina Haneke
Katharina Haneke
LRLea Roessig
Lea Roessig
APAnne‐Laure Pauleau
Anne‐Laure Pauleau
GSGeorg Stoecklin
Georg Stoecklin
The G2/M checkpoint coordinates DNA replication with mitosis and thereby prevents chromosome segregation in the presence of unreplicated or damaged DNA. Here, we show that the RNA‐binding protein TIAR is essential for the G2/M checkpoint and that TIAR accumulates in nuclear foci in late G2 and prophase in cells suffering from replication stress. These foci, which we named G2/M transition granules (GMGs), occur at low levels in normally cycling cells and are strongly induced by replication stress. In addition to replication stress response proteins, GMGs contain factors involved in RNA metabolism as well as CDK1. Depletion of TIAR accelerates mitotic entry and leads to chromosomal instability in response to replication stress, in a manner that can be alleviated by the concomitant depletion of Cdc25B or inhibition of CDK1. Since TIAR retains CDK1 in GMGs and attenuates CDK1 activity, we propose that the assembly of GMGs may represent a so far unrecognized mechanism that contributes to the activation of the G2/M checkpoint in mammalian cells.

13 September 2021 in Cancer Research
Verified
Journal Article
Open access
PDF file
SCSabrina Cappello
Sabrina Cappello
HSHsu-Min Sung
Hsu-Min Sung
CIChristian Ickes
Christian Ickes
CGChristine S. Gibhardt
Christine S. Gibhardt
AVAdina Vultur
Adina Vultur
IBIvan Bogeski
Ivan Bogeski
Despite impressive advances in melanoma-directed immunotherapies, resistance is common and many patients still succumb to metastatic disease. In this context, harnessing natural killer (NK) cells, which have thus far been sidelined in the development of melanoma immunotherapy, could provide therapeutic benefits for cancer treatment. To identify molecular determinants of NK cell–mediated melanoma killing (NKmK), we quantified NK-cell cytotoxicity against a panel of genetically diverse melanoma cell lines and observed highly heterogeneous susceptibility. Melanoma protein microarrays revealed a correlation between NKmK and the abundance and activity of a subset of proteins, including several metabolic factors. Oxidative phoshorylation, measured by oxygen consumption rate, negatively correlated with melanoma cell sensitivity toward NKmK, and proteins involved in mitochondrial metabolism and epithelial–mesenchymal transition were confirmed to regulate NKmK. Two- and three-dimensional killing assays and melanoma xenografts established that the PI3K/AKT/mTOR signaling axis controls NKmK via regulation of NK cell–relevant surface proteins. A “protein-killing-signature” based on the protein analysis predicted NKmK of additional melanoma cell lines and the response of patients with melanoma to anti-PD-1 checkpoint therapy. Collectively, these findings identify novel NK cell–related prognostic biomarkers and may contribute to improved and personalized melanoma-directed immunotherapies. Significance: NK-cell cytotoxicity assays and protein microarrays reveal novel biomarkers of NK cell–mediated melanoma killing and enable development of signatures to predict melanoma patient responsiveness to immunotherapies.

1 October 2020 in Current Opinion in Physiology
Verified
Journal Article
Closed access
CGChristine S Gibhardt
Christine S Gibhardt
DEDaria Ezeriņa
Daria Ezeriņa
HSHsu-Min Sung
Hsu-Min Sung
JMJoris Messens
Joris Messens
IBIvan Bogeski
Ivan Bogeski

31 March 2023
Verified
Other
Open access
SCSabrina Cappello
Sabrina Cappello
HSHsu-Min Sung
Hsu-Min Sung
CIChristian Ickes
Christian Ickes
CGChristine S. Gibhardt
Christine S. Gibhardt
AVAdina Vultur
Adina Vultur
IBIvan Bogeski
Ivan Bogeski
A file containing supplementary figures 1-8 and the supplementary table S1.